Pyxis Oncology, Inc.
Positive Phase 1 data for MICVO announced.
1 source·18/12, 12:26·sec.gov
10-Q form submitted!
1 source·03/11, 12:38·sec.gov
Quarterly financial results and corporate update announced.
1 source·03/11, 12:34·sec.gov
10-Q form submitted!
1 source·14/08, 20:29·sec.gov
Standard financial results and corporate update announcement.
1 source·14/08, 20:28·sec.gov
Revisions to patient enrollment for clinical trial announced.
1 source·04/08, 11:28·sec.gov
CFO retirement and appointment of new financial officer.
1 source·03/07, 10:02·sec.gov
Annual meeting results and board elections reported.
1 source·18/06, 20:18·sec.gov
10-Q form submitted!
1 source·15/05, 11:44·sec.gov
Company announces quarterly financial results and updates.
1 source·15/05, 11:38·sec.gov
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
·finviz.com·15/05, 11:05
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
·tradingview.com·02/04, 11:38
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
·globenewswire.com·02/04, 11:34
Pyxis Oncology to Present Preclinical Data for Micvo Cancer Drug Candidate
·tradingview.com·25/03, 21:46